NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,670 Cr | ₹1,684 Cr | ₹1,524 Cr | ₹1,669 Cr | ₹1,543 Cr |
What is the latest Revenue of NECTAR LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,670 Cr |
| Mar2024 | ₹1,684 Cr |
| Mar2023 | ₹1,524 Cr |
| Mar2022 | ₹1,669 Cr |
| Mar2021 | ₹1,543 Cr |
How is Revenue of NECTAR LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,670 Cr | -0.84 | |
| Mar2024 | ₹1,684 Cr | 10.53 | |
| Mar2023 | ₹1,524 Cr | -8.70 | |
| Mar2022 | ₹1,669 Cr | 8.13 | |
| Mar2021 | ₹1,543 Cr | - | |
Compare Revenue of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹207.1 Cr | -0.7% | -2.7% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.7% |
-2.7% |
-24% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses